MedsEngine Helps Medical Practices Unlock $30,000 Per Provider in Additional Annual Revenue

Details

According to MedsEngine, the use of their Cholesterol and Type 2 Diabetes modules offers significant financial benefits to medical practices. The estimate is calculated using a typical patient panel of 2,000 and relies on national averages and published financial data related to these chronic conditions. The system empowers clinicians by delivering evidence-based, guideline-directed medication recommendations in seconds, allowing providers more time for meaningful conversations with patients at the point of care. Users report improved medication adherence and better control rates. From a technical standpoint, MedsEngine is noted for its ease of integration. It integrates with EHR systems using FHIR technology, is SOC 2 Type II compliant, and is cloud-based. Integration typically requires only 10–20 hours (no installation) with existing EHR systems. Furthermore, the platform offers savings to health insurers. A study from Ochsner found that proper treatment of Type 2 Diabetes could reduce costs by $1,956 per patient annually, while controlling hypertension can save between $1,800 and $2,500 per patient annually. This highlights the value of standardized care management tools in chronic disease control.